Skip to main content
. Author manuscript; available in PMC: 2006 Mar 29.
Published in final edited form as: J Am Soc Nephrol. 2003 Jul;14(7 Suppl 2):S154–S165. doi: 10.1097/01.asn.0000070080.21680.cb

Table 1.

Enrollment by randomized group

Initial (Blinded) Therapy in Drug Regimen
Angiotensin converting enzyme inhibitor (ACEI) Beta-blocker (BB) Calcium channel blocker (DHPCCB) Total
MAP goal MAP ≤ 92 215 215 110 540
MAP 102 to 107 221 226 107 554
Total 436 441 227 1094